

Previously, we have reviewed the long-acting muscarinic antagonists (LAMAs) aclidinium, 1 glycopyrronium, 2 tiotropium 3 and umeclidinium, 4 and the long-acting beta 2 agonists (LABAs) indacaterol, 5. Plasma-theophylline concentration should be measured 5 days after starting oral treatment and at least 3 days after any dose adjustment. The management of symptoms of chronic obstructive pulmonary disease (COPD) typically involves the use of inhaled long-acting bronchodilators.Recommended blood monitoring on initiation of theophylline when required:.Patients with good control (ACT>20 / CAT 225mg twice a day), or medications that can affect blood levels, or currently have active level monitoring, will require blood level monitoring if switched to theophylline.NHS Lanarkshire Respiratory Team advice (February 2021): Lama (Tibetan:, Wylie: bla-ma 'chief' ) is a title for a teacher of the Dharma in Tibetan Buddhism. For information relating to interactions see BNF for details.ĭiscontinuation of aminophylline (Phyllocontin ®) tablets Llamas are very social animals and live with others as a herd. Theophylline has a narrow margin between therapeutic and toxic effects therapy should be monitored.Intravenous aminophylline is not a recommended drug in primary care having been superseded by nebulised beta 2–agonists.Bafadhel, M, et al Am J Respir Crit Care Med 2012, 186, 48-55. Targeted oral steroid therapy for acute exacerbations of COPD. Prescribing by brand is recommended for oral formulations due to variations in bioavailability. Print Bronchodilator combinations What are Bronchodilator combinations Bronchodilator combinations are generally inhalers or inhalation devices, which contain more than one bronchodilator, or a bronchodilator and a steroid. LAMA/LABA combination inhaler Eosinophilic airway inflammation inhaled corticosteroid.Study 1: Patients (N8588) with 1 moderate or severe exacerbation(s) in the year. See below for advice on further management of patients currently prescribed Phyllocontin ® products. Annual rate estimate: BREZTRI 0.13 ICS/LABA 0.16 LAMA/LABA 0.15.2.Please note - aminophylline preparations Phyllocontin ® Continus 225mg and Phyllocontin ® Forte Continus 350mg tablets have been discontinued ( MHRA Central Alerting System Feb 2021).
